Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes

Insights into the development of cell-based pacemakers

Tian Xue, Hee Cheol Cho, Fadi G. Akar, Suk Ying Tsang, Steven P. Jones, Eduardo Marbán, Gordon F. Tomaselli, Ronald A. Li

Research output: Contribution to journalArticle

375 Citations (Scopus)

Abstract

Background - Human embryonic stem cells (hESCs) derived from blastocysts can propagate indefinitely in culture while maintaining pluripotency, including the ability to differentiate into cardiomyocytes (CMs); therefore, hESCs may provide an unlimited source of human CMs for cell-based therapies. Although CMs can be derived from hESCs ex vivo, it remains uncertain whether a functional syncytium can be formed between donor and recipient cells after engraftment. Methods and Results - Using a combination of electrophysiological and imaging techniques, here we demonstrate that electrically active, donor CMs derived from hESCs that had been stably genetically engineered by a recombinant lentivirus can functionally integrate with otherwise-quiescent, recipient, ventricular CMs to induce rhythmic electrical and contractile activities in vitro. The integrated syncytium was responsive to the β-adrenergic agonist isoproterenol as well as to other pharmacological agents such as lidocaine and ZD7288. Similarly, a functional hESC-derived pacemaker could be implanted in the left ventricle in vivo. Detailed optical mapping of the epicardial surface of guinea pig hearts transplanted with hESC-derived CMs confirmed the successful spread of membrane depolarization from the site of injection to the surrounding myocardium. Conclusions - We conclude that electrically active, hESC-derived CMs are capable of actively pacing quiescent, recipient, ventricular CMs in vitro and ventricular myocardium in vivo. Our results may lead to an alternative or a supplemental method for correcting defects in cardiac impulse generation, such as cell-based pacemakers.

Original languageEnglish (US)
Pages (from-to)11-20
Number of pages10
JournalCirculation
Volume111
Issue number1
DOIs
StatePublished - Jan 4 2005
Externally publishedYes

Fingerprint

Cardiac Myocytes
Giant Cells
Myocardium
Epicardial Mapping
Adrenergic Agonists
Lentivirus
Human Embryonic Stem Cells
Blastocyst
Cell- and Tissue-Based Therapy
Lidocaine
Isoproterenol
Heart Ventricles
Guinea Pigs
Pharmacology
Injections
Membranes

Keywords

  • Cardiac development
  • Gene therapy
  • Pacemakers
  • Stem cells
  • Viruses

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes : Insights into the development of cell-based pacemakers. / Xue, Tian; Cho, Hee Cheol; Akar, Fadi G.; Tsang, Suk Ying; Jones, Steven P.; Marbán, Eduardo; Tomaselli, Gordon F.; Li, Ronald A.

In: Circulation, Vol. 111, No. 1, 04.01.2005, p. 11-20.

Research output: Contribution to journalArticle

@article{585091168d9e44a98f846b233d439649,
title = "Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: Insights into the development of cell-based pacemakers",
abstract = "Background - Human embryonic stem cells (hESCs) derived from blastocysts can propagate indefinitely in culture while maintaining pluripotency, including the ability to differentiate into cardiomyocytes (CMs); therefore, hESCs may provide an unlimited source of human CMs for cell-based therapies. Although CMs can be derived from hESCs ex vivo, it remains uncertain whether a functional syncytium can be formed between donor and recipient cells after engraftment. Methods and Results - Using a combination of electrophysiological and imaging techniques, here we demonstrate that electrically active, donor CMs derived from hESCs that had been stably genetically engineered by a recombinant lentivirus can functionally integrate with otherwise-quiescent, recipient, ventricular CMs to induce rhythmic electrical and contractile activities in vitro. The integrated syncytium was responsive to the β-adrenergic agonist isoproterenol as well as to other pharmacological agents such as lidocaine and ZD7288. Similarly, a functional hESC-derived pacemaker could be implanted in the left ventricle in vivo. Detailed optical mapping of the epicardial surface of guinea pig hearts transplanted with hESC-derived CMs confirmed the successful spread of membrane depolarization from the site of injection to the surrounding myocardium. Conclusions - We conclude that electrically active, hESC-derived CMs are capable of actively pacing quiescent, recipient, ventricular CMs in vitro and ventricular myocardium in vivo. Our results may lead to an alternative or a supplemental method for correcting defects in cardiac impulse generation, such as cell-based pacemakers.",
keywords = "Cardiac development, Gene therapy, Pacemakers, Stem cells, Viruses",
author = "Tian Xue and Cho, {Hee Cheol} and Akar, {Fadi G.} and Tsang, {Suk Ying} and Jones, {Steven P.} and Eduardo Marb{\'a}n and Tomaselli, {Gordon F.} and Li, {Ronald A.}",
year = "2005",
month = "1",
day = "4",
doi = "10.1161/01.CIR.0000151313.18547.A2",
language = "English (US)",
volume = "111",
pages = "11--20",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes

T2 - Insights into the development of cell-based pacemakers

AU - Xue, Tian

AU - Cho, Hee Cheol

AU - Akar, Fadi G.

AU - Tsang, Suk Ying

AU - Jones, Steven P.

AU - Marbán, Eduardo

AU - Tomaselli, Gordon F.

AU - Li, Ronald A.

PY - 2005/1/4

Y1 - 2005/1/4

N2 - Background - Human embryonic stem cells (hESCs) derived from blastocysts can propagate indefinitely in culture while maintaining pluripotency, including the ability to differentiate into cardiomyocytes (CMs); therefore, hESCs may provide an unlimited source of human CMs for cell-based therapies. Although CMs can be derived from hESCs ex vivo, it remains uncertain whether a functional syncytium can be formed between donor and recipient cells after engraftment. Methods and Results - Using a combination of electrophysiological and imaging techniques, here we demonstrate that electrically active, donor CMs derived from hESCs that had been stably genetically engineered by a recombinant lentivirus can functionally integrate with otherwise-quiescent, recipient, ventricular CMs to induce rhythmic electrical and contractile activities in vitro. The integrated syncytium was responsive to the β-adrenergic agonist isoproterenol as well as to other pharmacological agents such as lidocaine and ZD7288. Similarly, a functional hESC-derived pacemaker could be implanted in the left ventricle in vivo. Detailed optical mapping of the epicardial surface of guinea pig hearts transplanted with hESC-derived CMs confirmed the successful spread of membrane depolarization from the site of injection to the surrounding myocardium. Conclusions - We conclude that electrically active, hESC-derived CMs are capable of actively pacing quiescent, recipient, ventricular CMs in vitro and ventricular myocardium in vivo. Our results may lead to an alternative or a supplemental method for correcting defects in cardiac impulse generation, such as cell-based pacemakers.

AB - Background - Human embryonic stem cells (hESCs) derived from blastocysts can propagate indefinitely in culture while maintaining pluripotency, including the ability to differentiate into cardiomyocytes (CMs); therefore, hESCs may provide an unlimited source of human CMs for cell-based therapies. Although CMs can be derived from hESCs ex vivo, it remains uncertain whether a functional syncytium can be formed between donor and recipient cells after engraftment. Methods and Results - Using a combination of electrophysiological and imaging techniques, here we demonstrate that electrically active, donor CMs derived from hESCs that had been stably genetically engineered by a recombinant lentivirus can functionally integrate with otherwise-quiescent, recipient, ventricular CMs to induce rhythmic electrical and contractile activities in vitro. The integrated syncytium was responsive to the β-adrenergic agonist isoproterenol as well as to other pharmacological agents such as lidocaine and ZD7288. Similarly, a functional hESC-derived pacemaker could be implanted in the left ventricle in vivo. Detailed optical mapping of the epicardial surface of guinea pig hearts transplanted with hESC-derived CMs confirmed the successful spread of membrane depolarization from the site of injection to the surrounding myocardium. Conclusions - We conclude that electrically active, hESC-derived CMs are capable of actively pacing quiescent, recipient, ventricular CMs in vitro and ventricular myocardium in vivo. Our results may lead to an alternative or a supplemental method for correcting defects in cardiac impulse generation, such as cell-based pacemakers.

KW - Cardiac development

KW - Gene therapy

KW - Pacemakers

KW - Stem cells

KW - Viruses

UR - http://www.scopus.com/inward/record.url?scp=11244249952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11244249952&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000151313.18547.A2

DO - 10.1161/01.CIR.0000151313.18547.A2

M3 - Article

VL - 111

SP - 11

EP - 20

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 1

ER -